Bisogno T et al. |
Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation. |
1998 |
Eur. J. Biochem. |
pmid:9688276
|
Levin M and Mercola M |
Gap junctions are involved in the early generation of left-right asymmetry. |
1998 |
Dev. Biol. |
pmid:9806775
|
Aceto MD et al. |
Anandamide, an endogenous cannabinoid, has a very low physical dependence potential. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9808686
|
Murillo-RodrÃguez E et al. |
Anandamide modulates sleep and memory in rats. |
1998 |
Brain Res. |
pmid:9813364
|
Jaggar SI et al. |
The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder. |
1998 |
Neurosci. Lett. |
pmid:9774165
|
Fulton D and Quilley J |
Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9732371
|
Welch SP et al. |
Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9732392
|
Fields HL and Meng ID |
Watching the pot boil. |
1998 |
Nat. Med. |
pmid:9734389
|
Pate DW et al. |
Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. |
1998 |
Life Sci. |
pmid:9851310
|
Molina-Holgado F et al. |
The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway. |
1998 |
FEBS Lett. |
pmid:9738948
|
Stefano GB et al. |
Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. |
1998 |
Int. J. Cardiol. |
pmid:9687087
|
Stefano GB |
Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release. |
1998 |
J. Neuroimmunol. |
pmid:9610675
|
Smith FL et al. |
Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9610941
|
Gurwitz D and Kloog Y |
Do endogenous cannabinoids contribute to HIV-mediated immune failure? |
1998 |
Mol Med Today |
pmid:9612798
|
Prevot V et al. |
Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation. |
1998 |
Brain Res. |
pmid:9593913
|
Di Marzo V |
'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. |
1998 |
Biochim. Biophys. Acta |
pmid:9630590
|
Stefano GB et al. |
Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues. |
1998 |
Brain Res. |
pmid:9630717
|
Schmid PC et al. |
Alternative pathways of anandamide biosynthesis in rat testes. |
1998 |
Chem. Phys. Lipids |
pmid:9631536
|
Varga K et al. |
Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. |
1998 |
FASEB J. |
pmid:9707176
|
Mallet PE and Beninger RJ |
Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. |
1998 |
Life Sci. |
pmid:9651110
|
Qin C et al. |
Determination of anandamide amidase activity using ultraviolet-active amine derivatives and reverse-phase high-performance liquid chromatography. |
1998 |
Anal. Biochem. |
pmid:9683506
|
De Petrocellis L et al. |
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9653194
|
Berdyshev E et al. |
Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. |
1998 |
Life Sci. |
pmid:9718090
|
Jaggar SI et al. |
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. |
1998 |
Pain |
pmid:9696473
|
Bisogno T et al. |
Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9703957
|
Kondo S et al. |
Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis. |
1998 |
Arch. Biochem. Biophys. |
pmid:9637740
|
Stefano GB et al. |
Antagonism of LPS and IFN-gamma induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. |
1998 |
J. Cardiovasc. Pharmacol. |
pmid:9641464
|
Stefano GB et al. |
Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release. |
1998 |
J. Cardiovasc. Pharmacol. |
pmid:9641470
|
Mallet PE and Beninger RJ |
The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. |
1998 |
Psychopharmacology (Berl.) |
pmid:9862397
|
Stahl SM |
Getting stoned without inhaling: anandamide is the brain's natural marijuana. |
1998 |
J Clin Psychiatry |
pmid:9862600
|
Bonhaus DW et al. |
Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9864268
|
Ueda N et al. |
A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors. |
1998 |
J. Med. Invest. |
pmid:9864962
|
Mechoulam R et al. |
Endocannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9831287
|
Navarro M and RodrÃguez de Fonseca F |
The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease. |
1998 |
Neurobiol. Dis. |
pmid:9974172
|
Derocq JM et al. |
The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. |
1998 |
FEBS Lett. |
pmid:9563506
|
Chakrabarti A et al. |
Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice. |
1998 |
Brain Res. Bull. |
pmid:9434204
|
Lin S et al. |
Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. |
1998 |
J. Med. Chem. |
pmid:9876105
|
van Zadelhoff G et al. |
With anandamide as substrate plant 5-lipoxygenases behave like 11-lipoxygenases. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9675081
|
Wiley JL et al. |
Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. |
1998 |
Eur. J. Pharmacol. |
pmid:9760024
|
Lichtman AH et al. |
Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. |
1998 |
Eur. J. Pharmacol. |
pmid:9797029
|
Di Marzo V et al. |
Interactions between synthetic vanilloids and the endogenous cannabinoid system. |
1998 |
FEBS Lett. |
pmid:9801167
|
Stein EA et al. |
Selective effects of the endogenous cannabinoid arachidonylethanolamide (anandamide) on regional cerebral blood flow in the rat. |
1998 |
Neuropsychopharmacology |
pmid:9803424
|
Randall MD and Kendall DA |
Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery. |
1998 |
Eur. J. Pharmacol. |
pmid:9617751
|
Edgemond WS et al. |
Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. |
1998 |
Mol. Pharmacol. |
pmid:9658204
|
Tong W et al. |
Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis. |
1998 |
J. Med. Chem. |
pmid:9784095
|
Richardson JD et al. |
Antihyperalgesic effects of spinal cannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9600630
|
Hampson AJ et al. |
Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. |
1998 |
J. Neurochem. |
pmid:9453561
|
Kimura T et al. |
Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor. |
1998 |
Biol. Pharm. Bull. |
pmid:9556149
|
Qureshi J et al. |
Identification and characterization of a novel synthetic cannabinoid CP 55,940 binder in rat brain cytosol. |
1998 |
Mol. Cell. Biochem. |
pmid:9562238
|
Richardson JD et al. |
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. |
1998 |
Pain |
pmid:9539680
|